• Trials and Research

  Progressive MS Phase 2 NurOwn Trial Given $495K Grant by NMSS to Study Biomarkers

  Posted by MS News Today Moderator on November 28, 2019 at 9:42 am

  

  National MS Society gave BrainStorm Cell Therapeutics $495,330 to study biomarkers in its ongoing and enrolling Phase 2 trial of NurOwn in SPMS and PPMS. Click here to read the full story.

  What do you think about this research news?

  replied 4 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply